Unituxin

Showing 1 posts of 1 posts found.

Nice rejects United Therapeutics’ cancer drug

July 15, 2016
Medical Communications, Research and Development NICE, United Therapeutics, Unituxin, neuroblastoma

The National Institute for Health and Care Excellence (Nice) rejected United Therapeutics’ (Nasdaq: UTHR) Unituxin (dinutuximab) in combination therapy to …

The Gateway to Local Adoption Series

Latest content